$60.00
Recharge the cellular powerhouse and elevate your metabolic research with SS-31 (Elamipretide) 50 MG, the premier mitochondria-targeted tetrapeptide revolutionizing the scientific study of cellular longevity, bioenergetics, and ischemic recovery. Unlike conventional antioxidants that offer superficial protection, this innovative compound penetrates directly into the inner mitochondrial membrane to safeguard cardiolipin, restore cristae architecture, and reignite optimal ATP production at the very core of cellular energy synthesis. Whether you are pioneering breakthroughs in age-related metabolic decline, ischemia-reperfusion models, or cellular stress resilience, our ultra-pure, HPLC-verified SS-31 delivers unbeatable potency and unmatched laboratory consistency for your most ambitious discoveries.
Per vial
Form
Purity
CAS #
Molecular Formula
Molecular Weight
Half-life
Origin
Development Stage
Mechanism
Advanced Mitochondria-Targeted Peptide for Cardiolipin Stabilization & Bioenergetic Restoration
Investigate the forefront of mitochondrial physiology, cellular bioenergetics, and age-related metabolic research with SS-31 (Elamipretide) 50 MG, an elite-tier synthetic tetrapeptide engineered to selectively target and restore the inner mitochondrial membrane (IMM). Structurally classified among the Szeto-Schiller (SS) class of cell-permeable peptides, SS-31 features an alternating cationic-aromatic amino acid motif (D-Arg-Dmt-Lys-Phe-NH2) incorporating the modified amino acid 2′,6′-dimethyltyrosine (Dmt). This unique structural architecture allows the peptide to effortlessly penetrate cellular membranes and accumulate specifically within the mitochondrial matrix, independent of mitochondrial membrane potential.
Unlike conventional exogenous antioxidants that indiscriminately scavenge free radicals and can disrupt vital cellular signaling pathways, SS-31 operates upstream at the primary source of oxidative stress. It selectively binds with high affinity to cardiolipin—a critical anionic phospholipid expressed exclusively on the inner mitochondrial membrane. By stabilizing cardiolipin and protecting its association with cytochrome c, SS-31 prevents the conversion of cytochrome c into a pathological peroxidase enzyme while preserving its essential role as an electron carrier. This mechanism optimizes electron transport chain (ETC) supercomplex assembly, restores mitochondrial cristae architecture, enhances ATP synthesis, and significantly attenuates reactive oxygen species (ROS) production in ischemic, aging, and stressed cellular models.
Cardiolipin Stabilization: Binds selectively with high affinity to mitochondrial cardiolipin via electrostatic and hydrophobic interactions, preventing lipid peroxidation and protecting the structural integrity of the inner mitochondrial membrane.
Cytochrome c Protection: Modulates the cytochrome c/cardiolipin complex by inhibiting pathological peroxidase activity while preserving cytochrome c‘s vital function as an electron carrier within the respiratory chain.
Bioenergetic & ATP Optimization: Promotes the efficient assembly of respiratory complexes into supercomplexes, enhancing electron transport kinetics, state 3 respiration, and overall mitochondrial ATP production.
Upstream ROS Mitigation: Attenuates mitochondrial reactive oxygen species (ROS) production at the source without acting as an indiscriminate systemic antioxidant, preserving normal cellular physiological signaling.
Cristae Architecture Preservation: Demonstrated in extensive laboratory models to preserve mitochondrial cristae morphology, prevent mitochondrial swelling, and rescue cellular energy homeostasis following ischemia-reperfusion injury and aging.
Ultra-Pure Specification: Lyophilized and synthesized at an elite ≥98% purity level (HPLC and Mass Spectrometry verified) to guarantee exceptional precision, stability, and reproducibility in demanding metabolic and cellular assays.
This product is intended for laboratory research use only (RUO). Not for human or veterinary use.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Peak Vitality peptides have not been approved by Health Canada. Products by Peak Vitality have not been assessed for safety, efficacy and/or quality, may pose a range of serious health risks, and are intended for research purposes only. Products sold under Peak Vitality are not intended to treat, cure, or prevent diseases and/or conditions and may cause serious side effects.